Teleflex reported 2025 compensation for top executives, including two who left after the medtech CDMO sold off some big ...

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the beginning of ...

Shares of Teleflex Inc. TFX rallied 1.62% to $129.86 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.05% to 7,354.02 and ...

This was the stock's third consecutive day of gains.

Investors in Teleflex Incorporated TFX need to pay close attention to the stock based on moves in the options market lately.

From steam injections to drug-coated balloons, the options for treating an enlarged prostate are growing fast.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Brand Engagement Network, Inc. ("BEN"), a provider of enterprise-grade artificial intelligence solutions for the engagement layer of AI, today announced the advancement of Skye Salud to Phase 2 of its ...

System integrators and manufacturers building automated press?fit stations often face a common challenge: sourcing motors, ...

CVC Capital, GTCR bid to take medical device maker Teleflex private, source says Private equity firms CVC Capital Partners ‌and GTCR have submitted a joint bid to take medical equipment provider ...

As the Life Sciences Industry Awards marks its fourth year, a record 76 entries reflect the depth of talent and ambition ...

The Freesolve scaffold evaluated by Teleflex. [Image courtesy of Biotronik] Teleflex (NYSE:TFX) announced today that it began enrollment in the BIOMAG-III study of its Freesolve resorbable magnesium ...